Interestingly, in combination with clinical information, we found that CDK4 performed best in predicting the prognosis of patients in three NB cohorts, which is an essential tumor driver gene and may be a crucial prognostic marker for the Cluster 3 (Figure 4H) [54–56]. This evidence concerns the gene CDK4 and neuroblastoma.